About: El SRAA y el SARS-CoV-2: el acertijo a resolver

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: El SRAA y el SARS-CoV-2: el acertijo a resolver Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	El SRAA y el SARS-CoV-2: el acertijo a resolver
Creator	Choi, Marcelo Aiello, Ernesto Celeste Villa-Abrille, María Cingolani, Horacio De Hipertensión, Argentina Ennis, Irene Sociedad, Argentina
Source	Elsevier; Medline; PMC; WHO
abstract	Resumen El 31 de diciembre de 2019 se reportó el primer caso de COVID-19 en Wuhan, China, y desde entonces ha habido un interés creciente y sin precedentes por conocer todos los aspectos vinculados con esta nueva enfermedad. Uno de los temas que ha generado debate se vincula con la asociación entre la terapia antihipertensiva con inhibidores del sistema renina-angiotensina-aldosterona (SRAA) y la infección por el virus SARS-CoV-2. Si bien muchas preguntas siguen hoy día sin poder ser respondidas, la intención de este comunicado es informar a los profesionales de la salud acerca del estado actual de conocimiento. Dado que este es un tema en constante evolución, se recomienda su actualización a medida que se presenten nuevas evidencias. A continuación, daremos revisión a los estudios preclínicos y clínicos que relacionan el coronavirus con el SRAA. Abstract The first case of COVID-19 was reported on 31 December 2019 in Wuhan, China. Ever since there has been unprecedented and growing interest in learning about all aspects of this new disease. Debate has been generated as to the association between antihypertensive therapy with renin-angiotensin-aldosterone system (RAAS) inhibitors and SARS-CoV-2 infection. While many questions as yet remain unanswered, the aim of this report is to inform health professionals about the current state of knowledge. Because this is an ever-evolving topic, the recommendation is that it be updated as new evidence becomes available. Below, we provide a review of pre-clinical and clinical studies that link coronavirus to the RAAS.
has issue date	2020-05-27(xsd:dateTime)
bibo:doi	10.1016/j.hipert.2020.05.005
bibo:pmid	32527699
has license	els-covid
sha1sum (hex)	71e2026dc60e25697fc65f0e334f7aa56c039e7f
schema:url	https://doi.org/10.1016/j.hipert.2020.05.005
resource representing a document's title	El SRAA y el SARS-CoV-2: el acertijo a resolver
has PubMed Central identifier	PMC7250776
has PubMed identifier	32527699
schema:publication	Hipertens Riesgo Vasc
resource representing a document's body	covid:71e2026dc60e25697fc65f0e334f7aa56c039e7f#body_text
is schema:about of	named entity 'los' named entity 'sin' named entity 'Choi' named entity 'CONOCIMIENTO' named entity 'por' named entity 'actual' named entity 'Ennis' named entity 'infección' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'del' named entity 'SARS-CoV-2' named entity 'ECA2' named entity 'enalapril' named entity 'ECA2' named entity 'esta' named entity 'ECA2' named entity 'ADAM17' named entity 'SARS-CoV-2' named entity 'IL-6' named entity 'ECA2' named entity 'Otra' named entity 'ECA2' named entity 'Argentina' named entity 'fallo' named entity 'ECA2' named entity 'ADAM17' named entity 'TMPRSS2' named entity 'las guías' named entity 'SARS' named entity 'infección' named entity 'SARS-CoV-2' named entity 'COVID-19' named entity 'ECA2' named entity 'vacuna' named entity 'infección' named entity 'losartan' named entity 'Como' named entity 'ECA2' named entity 'SARS-CoV-2' named entity 'apelin' named entity 'ECA2' named entity 'ECA2' named entity 'ECA2' named entity 'La Ang' named entity 'Remdesivir' named entity 'ECA2' named entity 'Darunavir' named entity 'ECA2' named entity 'infección' named entity 'TMPRSS2' named entity 'Lopinavir/Ritonavir' named entity 'telmisartan' named entity 'ECA2' named entity 'TMPRSS2' named entity 'ECA2' named entity 'la Sociedad' named entity 'COVID-19' named entity 'ECA2' named entity 'vasoconstrictor' named entity 'ECA2' named entity 'SARS-CoV2' named entity 'ADAM17' named entity 'Favipiravir' named entity 'COVID-19' named entity 'ECA2' named entity 'esta' named entity 'infección' named entity 'SARS-CoV-2' named entity 'ECA2' named entity 'ECA2' named entity 'Arbidol' named entity 'ECA2' named entity 'infección' named entity 'esta'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software